Fact CheckerSign in

NCT05507190Completed

Self-management of Post COVID-19 Syndrome Using Wearable Biometric Technology

Source: ClinicalTrials.gov · Last updated 4 May 2025

Brief summary (registry, in English)

The main objective of this pilot study is to evaluate the impact of a self-management intervention using wearable biometric technology on post-COVID-19 syndrome. In addition, this pilot-study will provide information regarding validity, feasibility, patient compliance and satisfaction, valuable for the design of a future large-scale study.

Status (registry)
Completed
Study type
Interventional
Enrollment
20 (actual)
First submitted
28 Jul 2022
Start date
1 Dec 2023
Primary completion date
30 Jun 2024
Lead sponsor
University of Manitoba
NCT number
NCT05507190

What you commit to

  • Study type: Interventional
  • Participants enrolled: 20
  • From 1 Dec 2023 to the primary completion date, 30 Jun 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • History of neurological disease or mental illness

Other

  • Inability to ambulate independently without supervision
  • Inability to complete basic tasks on a smart phone or tablet

Who the study is looking for

  • Post-COVID-19 ≥ 3 months after infection.
  • Mild to severe persistent respiratory symptoms
  • Access to a home internet

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Riverview Health Centre
Coordinator of this site? Confirm its status		WinnipegCanadaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.